Genetic Technologies Limited (NASDAQ: GENE) (ASX: GTG) Soars 65% After Completing Two Ground-Breaking Genetic Risk Tests for Colorectal and Breast Cancers
Genetic Technologies Limited (NASDAQ: GENE) (ASX: GTG) is engaged as a diversified molecular diagnostics company, which focuses on cancer predictive ...
